UW’s Center for Commercialization Announces New Entrepreneurs-in-Residence

SEATTLE — The University of Washington’s Center for Commercialization (C4C), has recruited five additional industry experts as Entrepreneurs-in-Residence (EIRs). The C4C launched the EIR program in 2009 with support from the Washington State Economic Development Commission, the Washington State Legislature and in partnership with the Washington Research Foundation.

The newest EIRs are: Lars Johansson, a former Microsoft executive, active Cleantech angel investor and the co-chair of Northwest Energy Angels; Ronald Berenson, a medical oncologist who founded biotechnology companies HemaQuest Pharmaceuticals, Xcyte, and CellPro; Terri Butler, a 20-year technology veteran awarded patents for innovation in electrostatic printing and advanced materials while at 3M Company; Henry Berg, a director at A3 Alliance, whose background includes start-up efforts focused on mobile devices and patented work on collective intelligence business forecasting tools; and Stephanie Amoss, a marketing expert with more than 20 years experience in the healthcare and medical device industries.

They join current EIRS: Ken Myer, former president and CEO of the Washington Technology Industry Association, who is focusing on UW software spin-outs; David Kaplan, Seattle-based innovator and entrepreneur who has been working with UW researchers to further develop a regional smart grid R&D program; Thomas Schulte, a 30-year veteran in the medical device and diagnostic product industries, who is working with UW faculty on technologies for improved clinical diagnostics; and David Croniser, an engineer and pioneer in diagnostic imaging, who is focusing on innovations in the healthcare sector.

“We want to see more companies, more jobs, and more impact come out of our university’s research. We can’t expedite company spin-outs without talented entrepreneurs who recognize potential applications and market opportunities for UW research,” said Vice Provost and Executive Director of the C4C Linden Rhoads.

C4C introduces EIRs with specific domain expertise and industry experience to UW faculty carrying out translational research in related areas. EIRs have helped identify UW technologies with commercial promise and provide UW researchers with real-world insights about the commercialization process along with expertise about target markets, product development, and fundraising strategies.

Over the past two years since this program was launched, C4C’s EIR Program has helped dozens of projects develop commercially viable business plans. Several new companies have launched and are in various stages of fund-raising and commercialization, including Portage Bay Photonics, Cardiac Insight and CorazonX.

“The C4C’s EIR program has been the most radical and the most effective program for stimulating the formation of new companies,” says Ronald Howell, CEO of the Washington Research Foundation. “Staffed by qualified and experienced entrepreneurs, the program creates traction towards a start-up with a credible plan and basic management.”


About the University of Washington Center for Commercialization

UW researchers in hundreds of labs are making extraordinary innovations. As one of America’s leading federally funded public research universities, UW is producing innovations that have the power to change the world—from biofuel alternatives, to more effective treatments for Alzheimer’s disease and brain cancer, to a purification technology for drinking water in the developing world. The Center for Commercialization (C4C) is committed to getting these research outcomes into products, services, therapies, diagnostics, and cures to where they can impact millions of people. Since its founding, C4C has helped create some of the more than 250 start-up companies based on UW research. More information on the C4C can be viewed online at: http://depts.washington.edu/uwc4c/